The VITAL platform is testing Omron's Hypertension Management Program through July of 2019 among 200 patients with hypertension. This platform uses automated blood pressure monitors operated daily by patients in their environments, and through the Omron Hypertension Management app, sends clinical data to Omron's Dr. Dashboard, allowing clinicians to specifically assess the characteristics of the hypertension and to risk-stratify patients. High-risk patients can then be identified for earlier intervention, potentially resulting in improved health outcomes, reduction in acute events and an overall reduction in the cost of patient care.
According to the American Heart Association and the American College of Cardiology, nearly half of U.S. adults have hyperstension, one of the leading risk factors of heart attack and stroke. Spearheading the Omron test is lead investigator Dr. Francis Colangelo of Premier Medical Associates in Monroeville, Pa.
Highmark Health's VITAL Innovation Platform testing benefits
of innovations from Omron® Healthcare related to daily control of hypertension
and from Sensible Medical related to measurement of lung fluid in patients with
congestive heart failure